2023 Q1 Form 10-Q Financial Statement

#000155837023003432 Filed on March 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4
Revenue $54.68M $63.46M
YoY Change -18.25% -8.0%
Cost Of Revenue $41.96M $45.89M
YoY Change -16.04% -11.83%
Gross Profit $12.72M $17.57M
YoY Change -24.78% 3.76%
Gross Profit Margin 23.26% 27.69%
Selling, General & Admin $11.48M $14.87M
YoY Change -1.82% 7.54%
% of Gross Profit 90.3% 84.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.054M $962.0K
YoY Change 11.89% -7.77%
% of Gross Profit 8.29% 5.48%
Operating Expenses $11.48M $14.87M
YoY Change -1.82% 7.54%
Operating Profit $1.234M $2.698M
YoY Change -76.31% -13.11%
Interest Expense $16.00K $742.0K
YoY Change 128.57% 234.23%
% of Operating Profit 1.3% 27.5%
Other Income/Expense, Net $641.0K -$1.388M
YoY Change -350.39% 191.6%
Pretax Income $1.940M $2.052M
YoY Change -62.53% -28.03%
Income Tax $600.0K $628.0K
% Of Pretax Income 30.93% 30.6%
Net Earnings $1.330M $1.424M
YoY Change -62.38% -32.06%
Net Earnings / Revenue 2.43% 2.24%
Basic Earnings Per Share $0.20 $0.22
Diluted Earnings Per Share $0.20 $0.22
COMMON SHARES
Basic Shares Outstanding 6.583M 6.587M
Diluted Shares Outstanding 6.622M

Balance Sheet

Concept 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.89M $63.92M
YoY Change -36.81% -23.96%
Cash & Equivalents $56.89M $63.92M
Short-Term Investments
Other Short-Term Assets $11.24M $9.496M
YoY Change 20712.96% 873.95%
Inventory $168.6M $156.2M
Prepaid Expenses $10.16M $6.981M
Receivables $34.84M $38.44M
Other Receivables $0.00 $0.00
Total Short-Term Assets $271.6M $268.1M
YoY Change -7.28% -7.52%
LONG-TERM ASSETS
Property, Plant & Equipment $8.400M $8.483M
YoY Change -17.53% -20.02%
Goodwill
YoY Change
Intangibles $1.204M $1.246M
YoY Change -19.09% -20.38%
Long-Term Investments $9.914M $9.235M
YoY Change 3.11% -3.42%
Other Assets $9.914M $9.235M
YoY Change 3.11% -3.42%
Total Long-Term Assets $39.93M $38.17M
YoY Change -3.91% -11.37%
TOTAL ASSETS
Total Short-Term Assets $271.6M $268.1M
Total Long-Term Assets $39.93M $38.17M
Total Assets $311.5M $306.2M
YoY Change -6.86% -8.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $38.18M $38.78M
YoY Change -27.42% -20.66%
Accrued Expenses $4.456M $5.397M
YoY Change -7.42% -8.7%
Deferred Revenue $5.991M $4.839M
YoY Change -30.42% -43.69%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $67.32M $73.34M
YoY Change -18.3% -9.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.26M $10.19M
YoY Change -9.97% -23.26%
Total Long-Term Liabilities $11.35M $10.26M
YoY Change -10.03% -23.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $67.32M $73.34M
Total Long-Term Liabilities $11.35M $10.26M
Total Liabilities $78.66M $83.59M
YoY Change -17.2% -11.56%
SHAREHOLDERS EQUITY
Retained Earnings $180.2M $179.9M
YoY Change 1.14% 2.45%
Common Stock $659.0K $657.0K
YoY Change -0.3% -0.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $232.9M $222.6M
YoY Change
Total Liabilities & Shareholders Equity $311.5M $306.2M
YoY Change -6.86% -8.02%

Cashflow Statement

Concept 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income $1.330M $1.424M
YoY Change -62.38% -32.06%
Depreciation, Depletion And Amortization $1.054M $962.0K
YoY Change 11.89% -7.77%
Cash From Operating Activities -$7.986M -$6.407M
YoY Change -184.86% -211.87%
INVESTING ACTIVITIES
Capital Expenditures $214.0K -$565.0K
YoY Change -22.74% 5.61%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$2.000K
YoY Change -100.0% -99.74%
Cash From Investing Activities -$599.0K -$567.0K
YoY Change -28.26% -56.52%
FINANCING ACTIVITIES
Cash Dividend Paid $995.0K
YoY Change 6.19%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.781M -995.0K
YoY Change -20.74% 70.38%
NET CHANGE
Cash From Operating Activities -7.986M -6.407M
Cash From Investing Activities -599.0K -567.0K
Cash From Financing Activities -1.781M -995.0K
Net Change In Cash -7.034M -7.969M
YoY Change -217.9% -307.58%
FREE CASH FLOW
Cash From Operating Activities -$7.986M -$6.407M
Capital Expenditures $214.0K -$565.0K
Free Cash Flow -$8.200M -$5.842M
YoY Change -189.77% -193.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000315374
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-01-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
0-9143
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
HURCO COMPANIES, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IN
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-1150732
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
One Technology Way
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Indianapolis
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IN
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
46268
CY2023Q1 dei City Area Code
CityAreaCode
317
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
293-5309
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2023Q1 dei Trading Symbol
TradingSymbol
HURC
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6528493
CY2023Q1 us-gaap Revenues
Revenues
54682000
CY2022Q1 us-gaap Revenues
Revenues
66887000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41964000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
49980000
CY2023Q1 us-gaap Gross Profit
GrossProfit
12718000
CY2022Q1 us-gaap Gross Profit
GrossProfit
16907000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11484000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11697000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1234000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1643000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5210000
CY2023Q1 us-gaap Interest Expense
InterestExpense
16000
CY2022Q1 us-gaap Interest Expense
InterestExpense
7000
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
52000
CY2022Q1 us-gaap Interest Income Other
InterestIncomeOther
53000
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
29000
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
178000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
641000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-256000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1940000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5178000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
610000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1330000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3535000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6583000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6616000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6622000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6642000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1330000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3535000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10131000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1510000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
-25000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
46000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
82000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-149000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
-48000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
104000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-166000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
335000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9883000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1026000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11213000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2509000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56888000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63922000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34844000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38444000
CY2023Q1 us-gaap Inventory Net
InventoryNet
168608000
CY2022Q4 us-gaap Inventory Net
InventoryNet
156207000
CY2023Q1 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
1077000
CY2022Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
2515000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10162000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6981000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
271579000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
268069000
CY2023Q1 us-gaap Land
Land
879000
CY2022Q4 us-gaap Land
Land
868000
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
7352000
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
7352000
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
28032000
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
26532000
CY2023Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
4697000
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
4351000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
40960000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39103000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32560000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30620000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8400000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8483000
CY2023Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
7310000
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
7302000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1204000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1246000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9361000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8460000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3742000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3442000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9914000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9235000
CY2023Q1 hurc Assets Noncurrent Excluding Property And Equipment
AssetsNoncurrentExcludingPropertyAndEquipment
31531000
CY2022Q4 hurc Assets Noncurrent Excluding Property And Equipment
AssetsNoncurrentExcludingPropertyAndEquipment
29685000
CY2023Q1 us-gaap Assets
Assets
311510000
CY2022Q4 us-gaap Assets
Assets
306237000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
38178000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
40707000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5991000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4839000
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2261000
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3632000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4366000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3973000
CY2023Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
7443000
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
10751000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3213000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2611000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4456000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5397000
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1407000
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1426000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
67315000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
73336000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
81000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
67000
CY2023Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1281000
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1281000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5347000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4814000
CY2023Q1 us-gaap Deferred Credits And Other Liabilities Noncurrent
DeferredCreditsAndOtherLiabilitiesNoncurrent
4636000
CY2022Q4 us-gaap Deferred Credits And Other Liabilities Noncurrent
DeferredCreditsAndOtherLiabilitiesNoncurrent
4095000
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
11345000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10257000
CY2023Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2022Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12500000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12500000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6675917
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6645352
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6587694
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6566994
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
659000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
657000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63621000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63635000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
180212000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
179877000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11642000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21525000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
232850000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
222644000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
311510000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
306237000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1330000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3535000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
84000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-86000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
152000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-14000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-10000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
114000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1587000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-367000
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
388000
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-157000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1054000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
942000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
770000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
789000
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-5751000
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-3041000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2984000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5935000
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3204000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4156000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5244000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3862000
CY2023Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
815000
CY2022Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
67000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1816000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-922000
CY2023Q1 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-3308000
CY2022Q1 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-2557000
CY2023Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
401000
CY2022Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
1257000
CY2023Q1 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-553000
CY2022Q1 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-48000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
375000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-818000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7986000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9411000
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
214000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
277000
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
385000
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
303000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
262000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-599000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-835000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
270000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
117000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
995000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
937000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
313000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
208000
CY2023Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
743000
CY2022Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
1219000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1781000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2247000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3332000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-363000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7034000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5966000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
63922000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
84063000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56888000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
90029000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
238419000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3535000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1026000
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
581000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
117000
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1219000
CY2022Q1 us-gaap Dividends Cash
DividendsCash
937000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
239470000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
222644000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1330000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9883000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
461000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
270000
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
743000
CY2023Q1 us-gaap Dividends Cash
DividendsCash
995000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
232850000
CY2023Q1 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
-200000
CY2023Q1 us-gaap Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
-600000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21525000
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
9965000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
82000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11642000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
273103
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
32.90
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
129728
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
26.21
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
35960
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
36.91
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
39916
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
40.22
CY2023Q1 hurc Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Withheld In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldInPeriod
11950
CY2023Q1 hurc Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Withheld Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldWeightedAverageGrantDateFairValue
37.84
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
315005
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
28.57
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
800000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
800000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5800000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1330000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1330000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3535000
CY2022Q4 us-gaap Other Inventory Purchased Goods
OtherInventoryPurchasedGoods
46796000
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
18157000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
16539000
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
103553000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
96305000
CY2023Q1 us-gaap Inventory Gross
InventoryGross
172247000
CY2022Q4 us-gaap Inventory Gross
InventoryGross
159640000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3535000
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
18000
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
18000
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
39000
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
39000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1312000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1312000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3496000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3496000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6583000
CY2023Q1 hurc Weighted Average Number Of Diluted Shares Outstanding Before Dilutive Effect
WeightedAverageNumberOfDilutedSharesOutstandingBeforeDilutiveEffect
6583000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6616000
CY2022Q1 hurc Weighted Average Number Of Diluted Shares Outstanding Before Dilutive Effect
WeightedAverageNumberOfDilutedSharesOutstandingBeforeDilutiveEffect
6616000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
39000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
26000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6583000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6622000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6616000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6642000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1600000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1500000
CY2023Q1 us-gaap Other Inventory Purchased Goods
OtherInventoryPurchasedGoods
50537000
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3639000
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3433000
CY2023Q1 us-gaap Inventory Net
InventoryNet
168608000
CY2022Q4 us-gaap Inventory Net
InventoryNet
156207000
CY2022Q1 us-gaap Lease Cost
LeaseCost
1300000
CY2023Q1 us-gaap Lease Cost
LeaseCost
1300000
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1240000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1219000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1699000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
849000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3624000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2975000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1434000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
756000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
601000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
711000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10101000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
388000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
9713000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.024
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.31
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.32
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
173000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
171000
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
35000
CY2023Q1 hurc Number Of Guarantees
NumberOfGuarantees
9
CY2023Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
700000
CY2023Q1 hurc Term Of Product Warranty
TermOfProductWarranty
P1Y
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1426000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1516000
CY2023Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
590000
CY2022Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
646000
CY2023Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
674000
CY2022Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
680000
CY2023Q1 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
65000
CY2022Q1 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-12000
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1407000
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1470000
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
0
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1600000
CY2023Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
107000000.0
CY2022Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
102800000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001558370-23-003432-index-headers.html Edgar Link pending
0001558370-23-003432-index.html Edgar Link pending
0001558370-23-003432.txt Edgar Link pending
0001558370-23-003432-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hurc-20230131.xsd Edgar Link pending
hurc-20230131x10q.htm Edgar Link pending
hurc-20230131xex31d1.htm Edgar Link pending
hurc-20230131xex31d2.htm Edgar Link pending
hurc-20230131xex32d1.htm Edgar Link pending
hurc-20230131xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
hurc-20230131_cal.xml Edgar Link unprocessable
hurc-20230131_def.xml Edgar Link unprocessable
hurc-20230131_lab.xml Edgar Link unprocessable
hurc-20230131_pre.xml Edgar Link unprocessable
hurc-20230131x10q_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending